首页 | 本学科首页   官方微博 | 高级检索  
     

恶性肿瘤患者血清肌酸激酶同工酶高于肌酸激酶原因分析
引用本文:王 洋,田佳勋,余 宪,于 洪. 恶性肿瘤患者血清肌酸激酶同工酶高于肌酸激酶原因分析[J]. 现代肿瘤医学, 2015, 0(5): 676-677. DOI: 10.3969/j.issn.1672-4992.2015.05.29
作者姓名:王 洋  田佳勋  余 宪  于 洪
作者单位:辽宁省肿瘤医院检验科,辽宁 沈阳 110042
基金项目:辽宁省自然基金资助项目(编号:201202118)
摘    要:目的:探讨恶性肿瘤患者血清肌酸激酶同工酶(CK-MB)活性高于肌酸激酶(CK)的原因。方法:在VITROS5600全自动生化免疫分析仪上测定恶性肿瘤患者血清CK-MB和CK活性。结果:5612例恶性肿瘤患者血清中139例CK-MB活性高于CK活性,占恶性肿瘤患者的2.5%。恶性肿瘤患者中,O型与B型血占65%。结论:CK-MB活性高于CK活性除了方法学所致原因之外,恶性肿瘤患者免疫力低下或病情加重也是重要的影响因素。

关 键 词:恶性肿瘤患者  肌酸激酶同工酶  肌酸激酶

The analysis of malignant tumor patients' serum CK-MB higher than CK
Wang Yang,Tian Jiaxun,Yu Xian,Yu Hong. The analysis of malignant tumor patients' serum CK-MB higher than CK[J]. Journal of Modern Oncology, 2015, 0(5): 676-677. DOI: 10.3969/j.issn.1672-4992.2015.05.29
Authors:Wang Yang  Tian Jiaxun  Yu Xian  Yu Hong
Affiliation:Tumor Hospital of Liaoning Province,Liaoning Shenyang 110042,China.
Abstract:Objective:To explore the reason of malignant tumor patients' serum CK-MB higher than CK.Methods:Use VITROS5600 automatic biochemical analyzer to determine malignant patients serum CK-MB and CK activity.Results:In 139 cases of 5612 malignant tumors patients,CK-MB activity is higher than that of CK activity,accounting for 2.5%.Among these malignant tumor patients,O- and B-type blood accounted for 65%.Conclusion:Other than methodology reasons,immune system disorder and sicker patients are also factors that lead to CK-MB activity higher than CK.
Keywords:malignant tumor  Creatine kinase isoenzyme  Creatine kinase
本文献已被 万方数据 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号